These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
    Author: Hofmann SC, Technau K, Müller AM, Lübbert M, Bruckner-Tuderman L.
    Journal: J Am Acad Dermatol; 2007 May; 56(5 Suppl):S68-72. PubMed ID: 17097375.
    Abstract:
    Hypereosinophilic syndrome is a myeloproliferative disorder defined by unexplained, persistent hypereosinophilia with cutaneous or systemic involvement. We describe a patient with coexistence of hypereosinophilic syndrome and bullous pemphigoid. Treatment with the novel tyrosine kinase inhibitor imatinib mesylate resulted in durable remission of hypereosinophilia and skin lesions.
    [Abstract] [Full Text] [Related] [New Search]